1. Home
  2. companies
  3. JNJ

JNJ

J&J Wins U.S. Approval for Hepatitis C Combo With Gilead
J&J Wins U.S. Approval for Hepatitis C Combo With Gilead
Bloomberg
JNJ
FDA
Gilead Sciences
hepatitis C
Olysio
J&J, Pfizer, Novartis are the in-demand pharmas among job-seekers, LinkedIn says
J&J, Pfizer, Novartis are the in-demand pharmas among job-seekers, LinkedIn says
Fierce Pharma
JNJ
Pfizer
Novartis
J&J May Pay $250 Million to Settle 1,000 More Hip Claims
J&J May Pay $250 Million to Settle 1,000 More Hip Claims
Bloomberg
JNJ
hip implants
Pinnacle Hip
devices
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances
Yahoo
JNJ
Asia
innovation
In Ebola Crisis, New Vaccine Candidates Show Uncertain Promise
In Ebola Crisis, New Vaccine Candidates Show Uncertain Promise
Forbes
ebola virus
vaccines
Novavax
GSK
JNJ
Ebola: The making of a $1 billion drug
Ebola: The making of a $1 billion drug
CNN Money
ebola virus
GSK
NewLink Genetics
JNJ
government contracts
Bavarian Nordic
If It’s Bad For Merck, It’s Good For Gilead
If It’s Bad For Merck, It’s Good For Gilead
Barron's
Merck
Gilead Sciences
hepatitis C
Sovaldi
JNJ
Olysio
Johnson & Johnson Wins First Pinnacle Hip Implant Trial
Johnson & Johnson Wins First Pinnacle Hip Implant Trial
Bloomberg
JNJ
Pinnacle Hip
devices
hip implants
J&J, GSK ready to collaborate on Ebola vaccine work
J&J, GSK ready to collaborate on Ebola vaccine work
Yahoo/Reuters
JNJ
GSK
ebola virus
vaccines
J&J Says 250,000 Ebola Vaccine Doses to Be Ready by May
J&J Says 250,000 Ebola Vaccine Doses to Be Ready by May
Bloomberg
JNJ
vaccines
ebola virus
Janssen
Bavarian Nordic
J&J Ignored Reports Pinnacle Hip Implants Failed: Lawyer
J&J Ignored Reports Pinnacle Hip Implants Failed: Lawyer
Bloomberg
JNJ
Pinnacle Hip
hip implants
3 Drugs Critical to Johnson & Johnson's Future
3 Drugs Critical to Johnson & Johnson's Future
Motley Fool
JNJ
Olysio
Zytiga
Invega Sustenna
Xarelto
Stelara
Ebola Vaccine Trials Carry Risks for Companies in Chase
Ebola Vaccine Trials Carry Risks for Companies in Chase
Bloomberg
ebola virus
vaccines
GSK
JNJ
NewLink Genetics
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Motley Fool
JNJ
Gilead Sciences
Olysio
hepatitis C
Sovaldi
J&J hikes 2014 forecast for a third time
J&J hikes 2014 forecast for a third time
Yahoo/AP
JNJ
Johnson & Johnson shares gain after profit beat, raised outlook
Johnson & Johnson shares gain after profit beat, raised outlook
Marketwatch
JNJ
earnings
What to expect from Johnson & Johnson’s earnings
What to expect from Johnson & Johnson’s earnings
Marketwatch
JNJ
earnings
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
24/7 Wall St
Celgene
Novartis
Eli Lilly
JNJ
Bristol-Myers Squibb
Biogen Idec
How Will Johnson & Johnson (JNJ) Stock Be Affected by This Acquisition?
How Will Johnson & Johnson (JNJ) Stock Be Affected by This Acquisition?
TheStreet.com
JNJ
M&A
Alios BioPharma
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma
Marketwatch
JNJ
M&A
Alios BioPharma

Click here to subscribe to daily news headlines in your email inbox